12-42460406-A-G
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_153026.3(PRICKLE1):c.1899T>C(p.Phe633Phe) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.356 in 1,613,382 control chromosomes in the GnomAD database, including 104,864 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_153026.3 synonymous
Scores
Clinical Significance
Conservation
Publications
- epilepsy, progressive myoclonic, 1BInheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Unverricht-Lundborg syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- progressive myoclonus epilepsyInheritance: AR Classification: LIMITED Submitted by: ClinGen
- epilepsyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -21 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| PRICKLE1 | NM_153026.3 | c.1899T>C | p.Phe633Phe | synonymous_variant | Exon 8 of 8 | ENST00000345127.9 | NP_694571.2 | 
Ensembl
Frequencies
GnomAD3 genomes  0.320  AC: 48517AN: 151562Hom.:  8233  Cov.: 31 show subpopulations 
GnomAD2 exomes  AF:  0.349  AC: 87749AN: 251368 AF XY:  0.348   show subpopulations 
GnomAD4 exome  AF:  0.360  AC: 526194AN: 1461700Hom.:  96623  Cov.: 47 AF XY:  0.358  AC XY: 260349AN XY: 727156 show subpopulations 
Age Distribution
GnomAD4 genome  0.320  AC: 48551AN: 151682Hom.:  8241  Cov.: 31 AF XY:  0.318  AC XY: 23558AN XY: 74110 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
not specified    Benign:5 
- -
- -
Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
- -
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
not provided    Benign:3 
- -
- -
- -
Epilepsy, progressive myoclonic, 1B    Benign:1 
- -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at